PATH, Standard Diagnostics/Alere, and NIAID to collaborate on combined point-of-care rapid test for both river blindness and elephantiasis

New long-acting formulations may improve adherence and increase uptake, add an important tool to the portfolio of prevention interventions

Public health expert to serve on executive leadership team and oversee PATH’s international presence

Unique collaboration joins PATH, Unitus Seed Fund, Pfizer, and partners to increase access to health products and services, support Indian entrepreneurs, and improve health throughout India

MenAfriVac’s® introduction in routine childhood immunization programs will sustain long-term disease control in the region

The guidelines, the first in the region to align with updated recommendations from the World Health Organization, will help health care workers provide lifesaving screening and treatment

International delegation will gather to explore smart implementation of mHealth innovations in low-resource settings

Global public health expert to serve on PATH executive leadership team and oversee diverse portfolio

Pfizer Inc., the Bill & Melinda Gates Foundation, and the Children’s Investment Fund Foundation announce a novel price agreement

New diagnostics for a common enzyme deficiency will bolster malaria elimination efforts

Faster, easy-to-use test is the first in a suite of tools to help stamp out neglected tropical diseases in the world’s most vulnerable communities

Grant from Gates Foundation to PATH Malaria Vaccine Initiative

Vaccine/adjuvant combination against a leading cause of bacterial diarrhea shows great promise for saving children’s lives

PATH awarded Technical Assistance and Support for the Africa Region (TASC4 – Africa) subcontract

Dr. David Shoultz to lead work across one of PATH’s five innovation platforms

Report details new technologies and market landscape

The fight against diseases affecting the world’s most vulnerable communities requires new diagnostic tools

Dr. Cyril Engmann has extensive experience leading international maternal and newborn health initiatives

New partnership launches effort to improve access to diabetes medicines and technologies in low-income countries

PATH looks toward the future of maternal and newborn health technologies at the UN General Assembly and Clinton Global Initiative Annual Meeting

New award from the Wellcome Trust will support the clinical development of a vaccine against Shigella for children in the developing world

Caya® contoured diaphragm is safe, comfortable, and easy to use and expands nonhormonal contraceptive options for women

Washington Global Health Alliance award recognizes Tala de los Santos and global health “pioneers”

First shipment marks a critical step in improving access to treatment worldwide

Innovative partnership will drive development of devices and diagnostics to improve maternal, neonatal, and child health in South Africa and beyond

Joint PATH/University of Washington effort gains major support from the Paul G. Allen Family Foundation

Three-month contraceptive in Uniject™ injection device will be introduced in four African countries

Partnerships will be key to eventual scale-up of innovations to reduce child deaths

Dr. Rick King to lead work in transmission-blocking vaccines, evaluation technology

Product launch will introduce Caya® contoured diaphragm to North America

Events in Seattle and Berkeley, California, highlight progress and commitment toward eliminating malaria

Awards aim to identify the best ways to improve maternal, child nutrition

Point-of-care diagnostic test seeks to improve management of P. vivax malaria

Let’s reach the missing 3 million who have TB but don't know it

Experts say strengthening health systems and improving service delivery are crucial investments for solving health crises